Maysa M F El-Nagar

12PUBLICATIONS
23CO-AUTHORS
Molecular medicineCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Injury preventionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 06, 2026
RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527.

Thanaa A El-Masry, Maysa M F El-Nagar, Nageh A El Mahdy

|Nov 17, 2025
Antioxidant and Anti-Inflammatory Activities of Ulva lactuca Aqueous Extract: An In Vitro and In Vivo Study Supported With Phytochemical Profiling.

Badriyah S Alotaibi, Thanaa A El-Masry, Maisra M El-Bouseary

|Jan 08, 2025
Investigating the Antibacterial, Antioxidant, and Anti-Inflammatory Properties of a Lycopene Selenium Nano-Formulation: An In Vitro and In Vivo Study.

Reem Binsuwaidan, Thanaa A El-Masry, Maysa M F El-Nagar

|Nov 27, 2024
Potential Protective Effect of Orlistat: A Formulation of Nanocrystals Targeting Inflammation, Oxidative Stress, and Apoptosis in an Experimental Model of Doxorubicin-Induced Cardiotoxicity.

Maha Alsunbul, Thanaa A El-Masry, Enas I El Zahaby

|Sep 28, 2024
Hesperidin Nanoformulation: A Potential Strategy for Reducing Doxorubicin-Induced Renal Damage via the Sirt-1/HIF1-α/VEGF/NF-κB Signaling Cascade.

Fatemah A Alherz, Thanaa A El-Masry, Ghaleb A Oriquat

|Sep 27, 2024
Ameliorative Effect of Chitosan/Spirulina platensis Ethanolic Extract Nanoformulation against Cyclophosphamide-Induced Ovarian Toxicity: Role of PPAR-γ/Nrf-2/HO-1 and NF-kB/TNF-α Signaling Pathways.

May Almukainzi, Thanaa A El-Masry, Hanaa A Ibrahim

Pageof 2

Frequent Collaborators

4 joint publications

Enas I El Zahaby

3 joint publications

Mohamed M S Gaballa

3 joint publications

Fatemah A Alherz

2 joint publications

Reda M Gaafar